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INTRODUCTION
Hepatocellular carcinomas (HCCs) are consid-
ered to progress stepwise from well-differentiated
HCC to moderate, and finally to poorly differentiated
HCC along with enlargement and increasing malig-
nancy. Thus, well-differentiated HCCs are early
form of HCCs in hepatocarcinogenesis and the av-
erage diameter is less than 20 mm (1). HCC as well
as liver parenchyma is supplied by both the portal
vein and hepatic artery. In general, well -differen-
tiated HCCs progress to moderate-differentiated
HCCs with a transition of dominant blood supply
of the tumor from the portal tracts to arteries (2).
HCCs often contain various grades of fatty tissue.
This fatty metamorphosis are more frequent in small
well differentiated HCC nodules especially those
under 20 mm in diameter. It is reported that HCCs
in diameter from 11 to 15 mm contain fatty meta-
morphosis in 36.4%, while those in diameter of 3.0
cm have fatty change in 10% only at limited area or
peripheral lesion (3). The fatty metamorphosis is
also considered to be related to the ischemia and
metabolic disorder although its pathogenesis re-
mains unclear. It is very rare for a well-differentiated
HCC with fatty change to progress to over 30 mm.
Here, we present a case of well-differentiated HCC
of 65 mm in diameter with remarkable fatty meta-
morphosis.
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patient was referred to our institute because of a rapidly growing tumor in the left lobe
of the liver. Ultrasonography showed a hyperechoic lesion with a peripheral hypoechoic
area. Dynamic contrast-enhanced computed tomography (CT) scan in all three phases re-
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CASE REPORT
Computed tomography (CT) of a 68-year-old
man revealed a hepatic mass of 40 mm in diame-
ter. He had no relevant past history except for regu-
lar alcoholic habits. Ultrasound-guided needle bi-
opsy revealed unclear malignancy and remarkable
fatty metamorphosis pathologically. Thus, the pa-
tient was diagnosed as suspicious angiomyolipoma
and followed up without further treatments. After
3-months, however, the tumor was found to have
rapidly grown to 65 mm in diameter, and thus he
was transferred to our institute under suspicion of
a malignant tumor.
On the laboratory findings of this case at the time
of admission to our hospital, anti-hepatitis B virus
core antibody (HBc Ab) and anti-hepatitis B virus
e antibody (HBe Ab) were positive, while hepatitis
B surface antigen (HBs Ag) and anti-hepatitis C
(HCV) antibody were negative. Serum concentra-
tions of PIVKA, CA19-9, Dupan-2, and Span-1 were
elevated at 389 mAU/ml (normal range :40 mAU/
ml), 44 ng/dl (normal range :37 U/ml), 260 U/ml
(normal range :150 U/ml), and 54.8 U/ml (nor-
mal range :30 U/ml), respectively. The serum
alpha-fetoprotein (AFP) level was within normal
limit and AFP-L3 was not detected. ICG15 was 5.4%,
and he had no ascites or encephalopathy. Child-
Pugh scoring was grade A. Ultrasonography (US)
revealed a round high echoic tumor with a periph-
eral low echoic area in the left lobe of the liver
(Figure 1A). On pre-contrast CT, the tumor was de-
picted as a low density area suggestive of fatty com-
ponents. Dynamic contrast-enhanced CT in the ar-
terial phase showed irregular enhancement in the
tumor (Figure 1B). Portal and venous phases also
showed irregular internal enhancement without
wash-out (Figure 1C, D). Magnetic resonance im-
aging (MRI) of the tumor showed internal low inten-
sity on T1-weighted image, and iso intensity on T2-
weighted image (Figure 2A, B). Gd-EOB-DTPA-
enhanced MRI revealed a decrease of contrast up-
take in the hepatocyte phase. Additionally, CT and
MRI images showed extensive fatty infiltration of
the pancreas, which suggested a metabolic disorder
(Figure 2C). Considering the rapid growth, he was
preoperatively diagnosed as HCC. Differential di-
agnosis included hepatic angiomyolipoma (AML),
combined hepatocellular and cholangiocellular car-
cinoma, and cholangiolocellular carcinoma (CoCC).
Because AML consists of three components in vari-
able proportions, namely blood vessels, fat and
smooth muscle cells, it is difficult to differentiate fat-
containing HCC from AML preoperatively. Com-
bined hepatocellular and cholangiocellular carci-
noma and CoCC were considered because of the
increased serum Dupan-2 level, low enhancement
on contrast CT in the arterial phase and dilation of
the peripheral left intrahepatic bile duct on mag-
netic resonance cholangiopancreatography (MRCP)
(Figure 2D).
Figure 1 : Ultrasonography showed the round high echoic tumor
with the peripheral low echoic area in the left lobe of the liver
(A, arrowheads). Dynamic contrast -enhanced computed tomogra-
phy (CT) in the arterial phase demonstrated irregular enhance-
ment in the tumor (B, arrow). The portal and venous phases also
showed the irregular internal enhancement without wash-out
(C, D, arrow).
Figure 2 :Magnetic resonance imaging (MRI) showed the tu-
mor with internal low intensity on T1-weighted image (A), and
iso intensity on T2-weighted image (B). On CT image, pan-
creas is almost invisible due to lipomatosis (C, arrows). Mag-
netic resonance cholangiopancreatography showed dilation of
the peripheral left intrahepatic bile duct (D, arrow).
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Left lateral segmentectomy was performed with
clear surgical margins. Macroscopic examination of
the surgical specimen revealed a well circumscribed,
solid, yellowish tumor without apparent capsules
(Figure 3). Microscopically, most of the tumor was
composed of atypical cells with a trabecular pattern
and extensive fatty metamorphosis, and some of the
peripheral area of the tumor showed the presence
of pseudoglandular structures (Figure 4A, B). His-
tological diagnosis confirmed well-differentiated
HCC. The surrounding non-tumor tissue included
remarkable fatty change with Mallory body forma-
tion, infiltration of inflammatory cells, and fibrosis
in the portal area. Thus, the surrounding tissue was
diagnosed as non-alcoholic steatohepatitis (NASH)
(Figure 4C-F). The postoperative clinical course
was uneventful and the patient is still alive and well
without any signs of recurrence at 17 months after
the operation.
DISCUSSION
With the significant advances of diagnostic imag-
ing, HCC in an early stage can be detected. Some
HCC include fatty tissue within the tumor (3-5). It
is reported that 10 of 600 HCC cases demonstrated
fat metamorphosis (6). Fatty changes are noted to
be diffuse in smaller tumors within 35 mm and con-
centrated in lager tumors. As to the pathogenesis
of fatty metamorphosis in HCC, a relationship with
circulatory disturbance has been suggested (3, 7-
12). It is considered that the dominant blood supply
switches from portal tracts to arteries when HCC be-
comes approximately 15 mm in diameter. And then
some degree of ischemia and metabolic disorder
cause the development of fatty change, although
precise mechanisms remain to be understood. In
this case as well, it can be speculated that the ische-
mia and metabolic disorder in the tumor caused
the fatty metamorphosis. In most cases, this fatty
change is observed in HCC within 20 mm in diame-
ter but the tumor in the present case was as large as
65 mm in diameter. To our knowledge, there are no
reports describing such a large well-differentiated
Figure 3 : Operative findings and macroscopic examination
showed that the tumor was well -circumscribed, solid, and yel-
lowish in color without apparent capsules.
Figure 4 :Microscopically, most proportion of the tumor was
composed of atypical cells with trabecular pattern and extensive
fatty metamorphosis (A), and some proportion at peripheral area
of the tumor included pseudoglandular structure (B).
The surrounding non-cancerous area included remarkable fatty
change (C) with Mallory nodule (D, arrowhead), infiltration of
inflammatory cells (E), and bridging fibrosis (E), and diagnosed
as non-alcoholic steatohepatitis (NASH).
(A, B, C, D, E : Hematoxylin & eosin staining, D : Azan staining)
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HCC (over 40 mm in diameter) with remarkable
fatty change. Kudo et al reported that well-differen-
tiated HCCs abundant of arterial blood supply grow
more rapidly than those showing poor vascularity
(13). In our case, CT image in arterial phase showed
irregular enhancement of the tumor. Thus, this
might cause the rapid growth from 40 mm to 60
mm during 3 months.
Hepatic angiomyolipoma (AML) is a benign tu-
mor composed of various proportions of vessels, fat
and smooth muscle tissues. It exhibits various find-
ings on US, CT and MRI, and thus it is sometimes
quite difficult to distinguish a fat-containing hepa-
tocellular carcinoma from hepatic angiomyolipoma
(AML). In the present case, based on ultrasound-
guided fine needle biopsy (US-FNB) findings an ac-
curate diagnosis could not be made in the previous
hospital. While US-FNB is an effective method for
diagnosis of liver tumor and it is reported to accu-
rately diagnose HCC about 89.4% of nodules (14),
sometimes it cannot provide a precise diagnosis be-
cause of sampling error or a lower ability to distin-
guish well-differentiated HCC from benign lesions.
In addition, the tumor in this case included a large
amount of fatty tissue, rendering an accurate diag-
nosis more difficult.
Pancreatic lipomatosis is a relatively rare benign
condition and this is characterized by deposition of
fat cells in pancreatic parenchyma. Although the ex-
act pathogenesis behind this fatty replacement is
not well known, several predisposing factors have
been suggested, such as obesity, diabetes mellitus,
chronic pancreatitis, aging, and liver disease (15,
16). In our case, it is unclear whether this pancreatic
lipomatosis is related to extensive fatty metamor-
phosis of the tumor or non-alcoholic steatohepatitis.
However, there might be some degree of metabolic
disorder in this patient.
In conclusion, we described a rare case of large
well-differentiated HCC with remarkable fatty meta-
morphosis. When radiographic evaluation shows
fatty components in a liver tumor with a diameter
greater than 20 mm, HCC with fatty metamorphosis
should be taken into consideration.
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